{"id":17480,"date":"2014-01-12T01:30:00","date_gmt":"2014-01-12T00:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/vetro-nei-vaccini-la-merck-ritira-743-360-fiale-di-gardasil\/"},"modified":"2014-01-12T01:30:00","modified_gmt":"2014-01-12T00:30:00","slug":"vetro-nei-vaccini-la-merck-ritira-743-360-fiale-di-gardasil","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/vetro-nei-vaccini-la-merck-ritira-743-360-fiale-di-gardasil\/","title":{"rendered":"Glass in vaccines: Merck withdraws 743,360 vials of Gardasil"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 8pt\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-themecolor: text1\"><font size=\"3\">One hundred and forty medicines in chronic shortages, citizens forced into a treasure hunt from one pharmacy to another and loss of credibility on the part of pharmacies. complaint like this, <b>Michael DiIorio<\/b>, president of Federfarma Naples, an &quot;ancient but now explosive&quot; situation which has as a result &quot;a chronic shortage of many active ingredients which, in addition to creating inconvenience for citizens, makes those pharmacists without the aforementioned active ingredients lose credibility, not through their fault or will, but through<i> current market distortions<\/i>\u00bb. The origin of the phenomenon, explains Di Iorio, must be sought in the &quot;severe quotas&quot; with which the manufacturing companies respond to parallel exports according to European regulations which &quot;allow the free circulation of medicines within the EU&quot;. The phenomenon, he adds, &quot;also contributes to some pharmacies in possession of a license that authorizes the pharmacist to export&quot;. \u00abThe question must be raised and made known more\u00bb reiterates the regional president \u00abalso because it is widespread throughout the Italian territory, not just in Naples. Aifa should intervene, which has dedicated a site that is not updated to deficient products. It should block, even temporarily the export. The companies should intervene, which, on the one hand, should remove it from the export channel if they declare a drug subject to a quota. On the other, they should monitor what happens to the product when it arrives at the intermediary distributor or the pharmacist who acts as a distributor under the law 219 which assigns it this license\u00bb. But for now Di Iorio leaves some questions open: \u00abIs it permitted, under the quota regime, in application of article 105 of law 219, to practice exporting without having first satisfied the needs of the territory? Is AIFA&#039;s attitude justifiable which, despite being aware of the problem, does not intervene to correct it by law? Is a national reality that sees its own citizens as holders of the same duties as other European citizens but not gratified with the same rights, first of all that of medical care, even more sustainable?\u00bb.<\/font><\/span><span style=\"line-height: 107%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #333333; font-size: 10pt\"><br \/> <span style=\"mso-bidi-font-weight: bold\"><br \/> <i style=\"mso-bidi-font-style: normal\">Simone Zazzetta<b> &#8211; <\/b><\/i><\/span><\/span><i style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 107%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #333333; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">3 May 2013 \u2013 Pharmacist33<\/span><\/i><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 8pt\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 8pt\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 8pt\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 8pt\"><i style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 107%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #333333; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">&nbsp; <img","protected":false},"excerpt":{"rendered":"<p>Centoquaranta farmaci in carenza cronica, cittadini costretti a una caccia al tesoro da una&nbsp; farmacia all&#8217;altra e perdita di credibilit&agrave; da parte delle farmacie. Denuncia cos&igrave;, Michele Di Iorio, presidente di Federfarma Napoli, una situazione &laquo;antica ma ormai esplosiva&raquo; che ha come risultato &laquo;una carenza cronica di molti principi attivi che oltre a creare disagi &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17480","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17480"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17480\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}